Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Post by RazeKreationson Jul 10, 2022 11:36pm
341 Views
Post# 34814344

Share volume

Share volume Share volume at approx 1.4 million . Ok some may think that is too many shares. But. There are many companies with many times more shares that have a high share price and have no income . MBX has sold shares to obtain money to invest in upgrades, and those upgrades will improve the performance of the company. MBX is profitable and gaining cash and those upgrades will improve the variety of products available for the marketplace. Corona virus has played into the current market but MBX is much more than that. HPV, Monkey Pox,lung infections,and other pathogens are all part of MBX business. This current condition with the marketplace may finally shake some sense into the people that have invested into pipe dreams. It seems like a lot of people were more interested in the dream than reality. Microbix is a real company with real customers and huge growth potential. Real business takes time and patience and forward looking management. MBX is all of that and more. This is a transitional time that will pay off for those with the patience.
<< Previous
Bullboard Posts
Next >>